"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
| Descriptor ID |
D015497
|
| MeSH Number(s) |
B04.820.650.589.650.350.400
|
| Concept/Terms |
HIV-1- HIV-1
- Human immunodeficiency virus 1
- HIV-I
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
|
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 13 | 1 | 14 |
| 1995 | 15 | 4 | 19 |
| 1996 | 13 | 2 | 15 |
| 1997 | 8 | 1 | 9 |
| 1998 | 17 | 2 | 19 |
| 1999 | 11 | 3 | 14 |
| 2000 | 9 | 3 | 12 |
| 2001 | 12 | 4 | 16 |
| 2002 | 22 | 6 | 28 |
| 2003 | 5 | 4 | 9 |
| 2004 | 12 | 6 | 18 |
| 2005 | 6 | 4 | 10 |
| 2006 | 18 | 4 | 22 |
| 2007 | 11 | 5 | 16 |
| 2008 | 12 | 2 | 14 |
| 2009 | 7 | 6 | 13 |
| 2010 | 11 | 5 | 16 |
| 2011 | 9 | 5 | 14 |
| 2012 | 13 | 4 | 17 |
| 2013 | 13 | 3 | 16 |
| 2014 | 10 | 5 | 15 |
| 2015 | 10 | 5 | 15 |
| 2016 | 9 | 8 | 17 |
| 2017 | 9 | 3 | 12 |
| 2018 | 13 | 8 | 21 |
| 2019 | 8 | 3 | 11 |
| 2020 | 6 | 4 | 10 |
| 2021 | 2 | 1 | 3 |
| 2022 | 5 | 0 | 5 |
| 2023 | 7 | 1 | 8 |
| 2024 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins. Viruses. 2024 Sep 20; 16(9).
-
Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein. Int J Mol Sci. 2024 Sep 06; 25(17).
-
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fc? receptors during acute SHIVAD8-EO infection. Nat Commun. 2024 Aug 29; 15(1):7461.
-
False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clin Infect Dis. 2024 03 20; 78(3):674-680.
-
Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy. J Antimicrob Chemother. 2024 02 01; 79(2):370-374.
-
Texas Developmental Center for AIDS Research CFAR Diversity, Equity, and Inclusion Pathway Initiative Program. J Acquir Immune Defic Syndr. 2023 10 01; 94(2S):S80-S85.
-
Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms. Front Immunol. 2023; 14:1167965.
-
HIV-1 Vpu protein forms stable oligomers in aqueous solution via its transmembrane domain self-association. Sci Rep. 2023 09 06; 13(1):14691.
-
Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1. J Med Virol. 2023 09; 95(9):e29078.
-
Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5?32 and CCR5 C20S Heterozygote. J Infect Dis. 2023 07 14; 228(2):116-121.